Stock Overview

Haleon plc (HLN)

NYSE · Healthcare · Drug Manufacturers - Specialty & Generic

Haleon plc is a Healthcare company with a market capitalization of $43.55B, a trailing P/E ratio of 20.2, and a dividend yield of 1.93%.

Market Cap
$43.55B
P/E (TTM)
20.2
Forward P/E
18.0
Price/Sales
3.9
Price/Book
2.0
EV/EBITDA
14.0
Dividend Yield
1.93%
Beta
0.25
EPS (TTM)
$0.49
Profit Margin
14.4%
ROE
10.1%
Short % of Float
0.3%
Days to Cover
2.0
52W High
$11.12
52W Low
$8.61

5-Year Price History

Latest Annual Financials · FY ending December 31, 2025 · in GBP

Revenue
11.03B GBP
Gross Profit
6.99B GBP
Operating Income
2.41B GBP
Net Income
1.63B GBP
Free Cash Flow
1.97B GBP
Total Debt
8.55B GBP
Cash & Equivalents
1.32B GBP
Shareholder Equity
16.40B GBP

Recent Quarterly Earnings (EPS)

QuarterReportedActual EPSEstimateSurprise
Q1 2026April 29, 2026$0.00$0.12-100.0%
Q3 2025October 30, 2025$0.12$0.13-2.6%
Q2 2025August 7, 2025$0.09$0.11-15.6%
Q1 2025April 30, 2025$0.13$0.00
Q4 2024February 27, 2025$0.03$0.10-71.0%
Q3 2024October 31, 2024$0.12$0.11+9.1%

Short Interest

FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.

SettlementShares Short% of Shares OutDays to CoverChange
July 15, 202612,630,2312.0-10.5%
June 30, 202614,109,1691.3-6.1%
June 15, 202615,027,5681.5+28.5%
May 29, 202611,696,9241.6-21.5%
May 15, 202614,895,6761.3-2.5%
April 30, 202615,274,3092.2+23.6%
April 15, 202612,355,4791.9-35.9%
March 31, 202619,282,3812.0+16.5%

Other Drug Manufacturers - Specialty & Generic Stocks

Frequently Asked Questions

What is Haleon plc's market cap?

As of August 13, 2026, Haleon plc (HLN) has a market capitalization of $43.55B.

What is Haleon plc's P/E ratio?

Haleon plc trades at a trailing price-to-earnings (P/E) ratio of 20.2. Its forward P/E is 18.0.

Does Haleon plc pay a dividend?

Yes — Haleon plc pays a dividend yielding 1.93%, an annual payout of $0.07 per share.

What sector is HLN in?

Haleon plc is in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.

What is Haleon plc's short interest?

As of the July 15, 2026 FINRA settlement, 12,630,231 HLN shares were sold short. Days to cover: 2.0. FINRA publishes short interest twice a month, about nine business days after each settlement date.

What was Haleon plc's revenue?

In its latest reported fiscal year (ending December 31, 2025), Haleon plc reported revenue of 11.03B GBP and net income of 1.63B GBP.

Ask your own questions about HLN

Try mrmarket.ai free

Data as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.